According to the report “Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market”, published by Market Data Forecast, the global market is projected to reach USD 12.43 billion by 2020, at a CAGR of 9.00% from 2015 to 2020.

View Report @ http://www.marketdataforecast.com/market-reports/global-attention-deficit-hyperactivity-disorder-therapeutics-market-304/

Attention deficit hyperactivity disorder (ADHD), is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children below 12 years age as compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for the ADHD is not clear but, expected to be resulted due to genetic factors and environmental influences. ADHD results in improper functioning of nervous system that led to attention deficit and hyperactivity/impulsiveness condition. ADHD is characterized by certain symptoms include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of attention deficit hyperactivity disorder (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants-atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).

Download free sample report @ http://www.marketdataforecast.com/market-reports/global-attention-deficit-hyperactivity-disorder-therapeutics-market-304/request-sample

 Increasing advancements in medical field, growing number of researches in neurosciences, rising awareness about mental illness among people, and increasing focus of biotechnology & pharmaceutical companies to develop the innovative therapeutics for ADHD are driving the growth of global attention deficit hyperactivity disorder therapeutics market.

Global market for attention deficit hyperactivity disorder (ADHD) therapeutics is segmented on the basis of medication, psychotherapy, and education or training

On the basis of medication

Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Non-Stimulants
Atomoxetine
Bupropion
Guanfacine

On the basis of psychotherapy

Behavior Therapy
Cognitive Behavioral Therapy
Interpersonal Psychotherapy
Family Therapy

On the basis of education or training

Parent Management Training
Social Skills Training
School-Based Interventions

On the basis of Geography

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Segmentation: Write in form of bullet points

The key players in global attention deficit hyperactivity disorder (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).

About us:

Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:

Market Data Forecast, Inc.

Jubilee Gardens,

Hyderabad, India.

+1-888-702-9626 (U.S. TOLL FREE)

Email: abhishek@marketdataforecast.com